|
|
|
Volumn 13, Issue SUPPL. 1, 2002, Pages
|
|
Safety and efficacy of ET-743: The French experience
a
|
|
Author keywords
Chemotherapy; Ecteinascidin 743; Soft tissue sarcoma
|
|
Indexed keywords
ANTHRACYCLINE;
IFOSFAMIDE;
TRABECTEDIN;
1,3 DIOXOLANE DERIVATIVE;
ALKYLATING AGENT;
ISOQUINOLINE DERIVATIVE;
TETRAHYDROISOQUINOLINE DERIVATIVE;
ADULT;
AGED;
ALOPECIA;
ANEMIA;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER LOCALIZATION;
CANCER SIZE;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LEIOMYOSARCOMA;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MUCOSA INFLAMMATION;
NEUROTOXICITY;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RHABDOMYOLYSIS;
SOFT TISSUE SARCOMA;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TREATMENT PLANNING;
UTERUS SARCOMA;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
FRANCE;
INTRAVENOUS DRUG ADMINISTRATION;
MORTALITY;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
REVIEW;
SARCOMA;
SURVIVAL;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DIOXOLES;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
FRANCE;
HUMAN;
INFUSIONS, INTRAVENOUS;
ISOQUINOLINES;
MULTICENTER STUDIES;
SARCOMA;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
HUMANS;
TETRAHYDROISOQUINOLINES;
|
|
EID: 0036277072
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (22)
|
|
References (12)
|
